References
BROCHADO, A. R., TELZEROW, A., BOBONIS, J., BANZHAF, M., MATEUS, A., SELKRIG, J., HUTH, E., BASSLER, S., ZAMARRENO BEAS, J., ZIETEK, M., NG, N., FOERSTER, S., EZRATY, B., PY, B., BARRAS, F., SAVITSKI, M. M., BORK, P., GOTTIG, S. & TYPAS, A. 2018. Species-specific activity of antibacterial drug combinations. Nature, 559, 259-263.
CHAROENPHOL, P. & BERMUDEZ, H. 2014. Aptamer-targeted DNA nanostructures for therapeutic delivery. Molecular pharmaceutics,11, 1721-5.
DALY, S. M., STURGE, C. R., FELDER-SCOTT, C. F., GELLER, B. L. & GREENBERG, D. E. 2017. MCR-1 Inhibition with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to Polymyxin in Escherichia coli. Mbio, 8.
EL-ANDALOUSSI, S., JARVER, P., JOHANSSON, H. J. & LANGEL, U. 2007. Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study. The Biochemical journal,407, 285-92.
FRAZIER, K. S. 2015. Antisense Oligonucleotide Therapies: The Promise and the Challenges from a Toxicologic Pathologist’s Perspective.Toxicologic Pathology, 43, 78-89.
GARCIA-CHAUMONT, C., SEKSEK, O., GRZYBOWSKA, J., BOROWSKI, E. & BOLARD, J. 2000. Delivery systems for antisense oligonucleotides.Pharmacology & therapeutics, 87, 255-77.
GOOD, L., AWASTHI, S. K., DRYSELIUS, R., LARSSON, O. & NIELSEN, P. E. 2001. Bactericidal antisense effects of peptide-PNA conjugates.Nature biotechnology, 19, 360-4.
GOOD, L., SANDBERG, R., LARSSON, O., NIELSEN, P. E. & WAHLESTEDT, C. 2000. Antisense PNA effects in Escherichia coli are limited by the outer-membrane LPS layer. Microbiology (Reading, England), 146 ( Pt 10), 2665-70.
GOODMAN, R. P., SCHAAP, I. A. T., TARDIN, C. F., ERBEN, C. M., BERRY, R. M., SCHMIDT, C. F. & TURBERFIELD, A. J. 2005. Rapid chiral assembly of rigid DNA building blocks for molecular nanofabrication. Science (New York, N Y ), 310, 1661-5.
HEGARTY, J. P. & STEWART, D. B., SR. 2018. Advances in therapeutic bacterial antisense biotechnology. Appl Microbiol Biotechnol,102, 1055-1065.
HU, Y., CHEN, Z., ZHANG, H., LI, M., HOU, Z., LUO, X. & XUE, X. 2017. Development of DNA tetrahedron-based drug delivery system. Drug delivery, 24, 1295-1301.
KIM, K.-R., KIM, D.-R., LEE, T., YHEE, J. Y., KIM, B.-S., KWON, I. C. & AHN, D.-R. 2013. Drug delivery by a self-assembled DNA tetrahedron for overcoming drug resistance in breast cancer cells. Chemical communications (Cambridge, England), 49, 2010-2.
KIM, W., ZHU, W., HENDRICKS, G. L., VAN TYNE, D., STEELE, A. D., KEOHANE, C. E., FRICKE, N., CONERY, A. L., SHEN, S., PAN, W., LEE, K., RAJAMUTHIAH, R., FUCHS, B. B., VLAHOVSKA, P. M., WUEST, W. M., GILMORE, M. S., GAO, H., AUSUBEL, F. M. & MYLONAKIS, E. 2018. A new class of synthetic retinoid antibiotics effective against bacterial persisters.Nature, 556, 103-107.
LEE, D. S., QIAN, H., TAY, C. Y. & LEONG, D. T. 2016. Cellular processing and destinies of artificial DNA nanostructures. Chem Soc Rev, 45, 4199-225.
LEE, H., LYTTON-JEAN, A. K. R., CHEN, Y., LOVE, K. T., PARK, A. I., KARAGIANNIS, E. D., SEHGAL, A., QUERBES, W., ZURENKO, C. S., JAYARAMAN, M., PENG, C. G., CHARISSE, K., BORODOVSKY, A., MANOHARAN, M., DONAHOE, J. S., TRUELOVE, J., NAHRENDORF, M., LANGER, R. & ANDERSON, D. G. 2012. Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nature nanotechnology, 7, 389-93.
LINKO, V., ORA, A. & KOSTIAINEN, M. A. 2015. DNA Nanostructures as Smart Drug-Delivery Vehicles and Molecular Devices. Trends in biotechnology, 33, 586-594.
MENG, J., HE, G., WANG, H., JIA, M., MA, X., DA, F., WANG, N., HOU, Z., XUE, X., LI, M., ZHOU, Y. & LUO, X. 2015. Reversion of antibiotic resistance by inhibiting mecA in clinical methicillin-resistant Staphylococci by antisense phosphorothioate oligonucleotide. The Journal of antibiotics, 68, 158-64.
READMAN, J. B., DICKSON, G. & COLDHAM, N. G. 2017. Tetrahedral DNA Nanoparticle Vector for Intracellular Delivery of Targeted Peptide Nucleic Acid Antisense Agents to Restore Antibiotic Sensitivity in Cefotaxime-Resistant Escherichia coli. Nucleic acid therapeutics,27, 176-181.
ROWNICKI, M., WOJCIECHOWSKA, M., WIERZBA, A. J., CZARNECKI, J., BARTOSIK, D., GRYKO, D. & TRYLSKA, J. 2017. Vitamin B12 as a carrier of peptide nucleic acid (PNA) into bacterial cells. Scientific reports, 7, 7644.
SETYAWATI, M. I., KUTTY, R. V., TAY, C. Y., YUAN, X., XIE, J. P. & LEONG, D. T. 2014. Novel Theranostic DNA Nanoscaffolds for the Simultaneous Detection and Killing of Escherichia coli and Staphylococcus aureus. Acs Applied Materials & Interfaces,6, 21822-21831.
WALSH, A. S., YIN, H., ERBEN, C. M., WOOD, M. J. A. & TURBERFIELD, A. J. 2011. DNA cage delivery to mammalian cells. ACS nano,5, 5427-32.
XIA, Z., WANG, P., LIU, X., LIU, T., YAN, Y., YAN, J., ZHONG, J., SUN, G. & HE, D. 2016. Tumor-Penetrating Peptide-Modified DNA Tetrahedron for Targeting Drug Delivery. Biochemistry, 55, 1326-31.
ZHANG, Y., MA, W., ZHU, Y., SHI, S., LI, Q., MAO, C., ZHAO, D., ZHAN, Y., SHI, J., LI, W., WANG, L., FAN, C. & LIN, Y. 2018. Inhibiting Methicillin-Resistant Staphylococcus aureus by Tetrahedral DNA Nanostructure-Enabled Antisense Peptide Nucleic Acid Delivery.Nano letters .